title: Multiplex immunoassay analysis of plasma shows differences in biomarkers related to manic or mixed mood states in bipolar disorder patients.
abstract: BACKGROUND
  The molecular understanding of bipolar disorder (BD) aetiology has advanced over the last years through the identification of peripheral disease biomarkers. Here, we have attempted to identify plasma biomarkers associated with distinct BD mood states.
  
  
  METHODS
  Plasma from BD patients with either a current manic (n=29) or mixed (n=17) mood state and healthy controls (n=53) were analysed using a multiplex immunoassay platform. A total of 145 hormones, growth factors, transport proteins and inflammatory factors were measured.
  
  
  RESULTS
  Plasma levels of the hormones C-peptide, progesterone and insulin, and the inflammatory protein cancer antigen 125 were altered in both mood states. The hormone peptide YY and the growth factor trafficking protein sortilin were changed only in mania patients. Finally, the inflammatory factors haptoglobin, chemokine CC4 and matrix metalloproteinase 7 were altered specifically in mixed mood patients.
  
  
  CONCLUSIONS
  This study was limited by a small sample size, potential confounding effects of multiple drug treatments in the patient groups, and lack of dietary restrictions at sampling.
  
  
  CONCLUSIONS
  Plasma from mania and mixed mood BD patients revealed similar changes in proteins related to insulin signalling, suggesting that these could be trait biomarkers. However, mania patients showed specific changes in hormonal and growth factor functions and mixed mood patients had a higher number of changes in inflammation-related molecules. Further studies of these and other biomarker candidates will increase our understanding of the systemic biological pathways affected in different BD mood states. This could lead to the identification of differential surrogate readouts and potential new drug targets for improved treatment outcomes.
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Frieder
authors.initials: F
authors.lastname: Haenisch
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Murtada
authors.initials: M
authors.lastname: Alsaif
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Paul C
authors.initials: PC
authors.lastname: Guest
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Hassan
authors.initials: H
authors.lastname: Rahmoune
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, USA.
authors.forename: Robert H
authors.initials: RH
authors.lastname: Yolken
authors.affiliation: Sheppard Pratt Health System, Baltimore, USA. Electronic address: faithbdickerson@gmail.com.
authors.forename: Faith
authors.initials: F
authors.lastname: Dickerson
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom. Electronic address: sb209@cam.ac.uk.
authors.forename: Sabine
authors.initials: S
authors.lastname: Bahn
mesh_terms: D000328:Adult; D000339:Affect; D015415:Biomarkers / Q000097:blood; D001714:Bipolar Disorder / Q000097:blood* / Q000188:drug therapy / Q000523:psychology*; D002352:Carrier Proteins / Q000097:blood; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D007118:Immunoassay / Q000379:methods / Q000706:statistics & numerical data*; D007249:Inflammation / Q000097:blood; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood; D008297:Male
chemical_list: D015415:Biomarkers; D002352:Carrier Proteins; D006728:Hormones; D036341:Intercellular Signaling Peptides and Proteins
keywords: Bipolar disorder; Inflammatory factors; Insulin; Mania; Mixed mood states; Multiplex Immunoassay